Skip to main content

Table 1 Clinicopathological features of 2031 p-MMR and d-MMR GC patients

From: Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer

Variables

MMR status

p value

p-MMR

d-MMR

Sex

  

0.102

 male

516/2031 (25.4%)

55/2031 (2.7%)

 

 female

1375/2031 (67.7%)

85/2031 (4.2%)

 

Lauren type

  

0.012*

 Diffuse/mixed

1201/2031 (59.1%)

74/2031 (3.6%)

 

 intestinal

690/2031 (34%)

66/2031 (3.2%)

 

Differentiation

  

0.256

 poorly

1264/2031 (62.2%)

87/2031 (4.3%)

 

 well-moderately

627/2031 (30.9%)

53/2031 (2.6%)

 

T stage

  

0.038

 pT3 + T4

1193/2031 (58.7%)

88/2031 (4.3%)

 

 pT1 + T2

698/2031 (34.4%)

52/2031 (2.6%)

 

Lymphnode metastasis

  

0.246

 LNM+

1121/2031 (55.2%)

76/2031 (3.7%)

 

 LNM-

770/2031 (37.9%)

64/2031 (3.2%)

 

PD-L1 expression

  

0.000*

 PD-L1 -

1337/2031 (65.8%)

69/2031 (3.4%)

 

 PD-L1 > =1%

554/2031 (27.3%)

71/2031 (3.5%)

Â